カテゴリ： Grand View Research, 世界, 医療/バイオ

世界の栄養補助食品CDMO市場2023-2030：市場規模、シェア、動向分析

■ 英語タイトル：Nutraceuticals CDMO Market Size, Share & Trends Analysis Report By Dosage Form (Tablets, Softgel), By Services (Product Formulation & Development, Research & Development), By Company Size, By Region, And Segment Forecasts, 2023 - 2030

調査会社Grand View Research社が発行したリサーチレポート（データ管理コード：GRV23JUN081）■ 発行会社/調査会社：Grand View Research
■ 商品コード：GRV23JUN081
■ 発行日：2023年5月29日
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：175
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後3営業日）
■ 販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,360,400見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Grand View Research社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の栄養補助食品CDMO市場2023-2030：市場規模、シェア、動向分析]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

グランドビューリサーチ社の市場調査では、世界の栄養補助食品CDMO市場規模が、2030年に678.3億ドルに及び、2023年から2030年までの予測期間中に年平均成長率は7.7％を記録すると予測されています。こちらのレポートでは、栄養補助食品CDMOの世界市場について調査・分析を行い、調査手法・範囲、エグゼクティブサマリー、市場変動・動向・範囲、剤形別（錠剤・カプセル、粉末、ソフトジェル、その他）分析、サービス別（製品処方・開発、製造・包装、研究・開発、規則遵守、その他）分析、企業規模別（小規模企業、中堅企業、大企業）分析、地域別（北米、ヨーロッパ、アジア太平洋中南米、中東・アフリカ）分析、競争状況などの内容を記載しています。また、市場調査の企業情報には、Catalent Inc.、Lonza Group AG、Nutrascience Labs、Robison Pharma, Inc.、Health Wright Products、Innovations in Nutrition + Wellness、INPHARMA S.p.A.、Aenova Group、NutraPakUSA、SFI Health Solutionsなどが含まれています。
・調査手法・範囲
・エグゼクティブサマリー
・市場変動・動向・範囲
・世界栄養補助食品CDMOの市場規模：剤形別
- 錠剤・カプセル状栄養補助食品の市場規模
- 粉末状栄養補助食品の市場規模
- ソフトジェル状栄養補助食品の市場規模
- その他栄養補助食品の市場規模
・世界栄養補助食品CDMOの市場規模：サービス別
- 製品処方・開発における市場規模
- 製造・包装における市場規模
- 研究・開発における市場規模
- 規則遵守における市場規模
- その他サービスにおける市場規模
・世界栄養補助食品CDMOの市場規模：企業規模別
- 小規模企業における市場規模
- 中堅企業における市場規模
- 大企業における市場規模
・世界栄養補助食品CDMOの市場規模：地域別
- 北米の栄養補助食品CDMO市場規模
- ヨーロッパの栄養補助食品CDMO市場規模
- アジア太平洋の栄養補助食品CDMO市場規模
- 中南米の栄養補助食品CDMO市場規模
- 中東・アフリカの栄養補助食品CDMO市場規模
・競争状況

Nutraceuticals CDMO Market Growth & Trends

The global nutraceuticals CDMO market size is expected to reach USD 67.83 billion by 2030, expanding at 7.7% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. Rising awareness of nutraceuticals products, demand for nutraceuticals with medical benefits, and technological advancement are the some of the major factors driving the market growth.

Furthermore, increasing demand for organic and natural products is expected to drive market growth. CDMOs are responding to this demand by providing services related to sustainable manufacturing practices, natural ingredient sourcing, and certifications for organic product manufacturing. Moreover, increasing technological advancements to improve manufacturing processes and enhance product quality is anticipated to create growth opportunities for market growth. The technological advancement includes the adoption of new delivery systems, such as microencapsulation, and nano-emulsions, to improve the bioavailability and stability of nutraceutical ingredients.

Nutraceutical CDMOs are witnessing an increasing demand for customized solutions to meet the specific requirements of individual customers. Key companies are providing personalized nutrition solutions based on a person’s unique health and well-being requirements. This is accomplished by lifestyle assessments, genetic testing, and personalized recommendations. Moreover, companies are exploring new delivery systems for nutraceuticals, such as nanoparticle delivery and liposome encapsulation to enhance the efficacy of the products.

On the other hand, key companies in the market undertaking various strategic initiatives such as partnerships, new service launches, mergers and acquisitions, and regional expansion to strengthen their market presence. For instance, in August 2022, Zerion Pharma entered into a partnership with Hovione to cover the use of the Dispersome platform in nutraceuticals. As part of this initiative, Hovione and ZERION will use the Dispersome technology to scale up and create commercial formulations of the antioxidant. Moreover, in October 2019, Sirio Pharma, a China-based nutraceutical contract development organization launched a plant-based nutraceutical service package. The company is actively promoting its integrated solutions for plant-based nutraceuticals through the event.

Nutraceuticals CDMO Market Report Highlights

• Based on dosage forms, the tablets & capsules segment dominated the market share of 61.43% in 2022. The growth of the segment is attributed to the formulation flexibility it offers to developers. Capsules are available in different sizes (000 to 5), offering developers with various dosing options

• On the other hand, the soft gel segment is expected to hold a significant market share in the coming years. For individuals who have trouble swallowing tablets or are averse to the idea of injections, the soft gel remains a preferred option because they are simple to take

• Based on services, manufacturing, and packaging captured a major share in 2022. Manufacturing requires substantial equipment, infrastructure, and skilled staff. By outsourcing these functions to CDMOs, nutraceutical companies can minimize capital expenses and operational expenses associated with maintaining in-house production capabilities

• Mid-sized companies held a major share of the company size segment in 2022. Mid-sized companies can provide specialized services based on the unique requirements of their customers. Mid-sized CROs can quickly adapt to changing client needs and offer individualized solutions

• North America dominated the market in 2022 due to factors such as rising awareness regarding nutraceuticals,changing lifestyles, and growing health concerns among consumers

• Some of the major players include Catalent Inc.; Lonza; NUTRASCIENCE LABS; Robinson Pharma, Inc.; Health Wright Products, Inc.; Innovations in Nutrition + Wellness; among others.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

Table of Contents

Chapter 1. Research Methodology And Scope
1.1. Market Segmentation & Scope
1.1.1. Segment Definitions
1.1.2. Dosage Form
1.1.3. Company Size
1.1.4. Services
1.2. Regional Scope
1.3. Estimates And Forecast Timeline
1.4. Objectives
1.4.1. Objective-1
1.4.2. Objective-2
1.4.3. Objective-3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. GVR’s Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information Or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.9.2. Parent Market Analysis
1.10. List Of Secondary Sources
1.11. List Of Abbreviations
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Nutraceuticals CDMO Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing Demand For Nutraceuticals & Rising Outsourcing Of R&D Activities
3.2.1.2. Advancement In Technology
3.2.1.3. Favorable Government Regulations
3.2.2. Market Restraint Analysis
3.2.2.1. Limited availability of Raw materials
3.2.2.2. High production costs and regulatory challenges
3.3. Nutraceuticals CDMO Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Nutraceuticals CDMO Market: Dosage Form Estimates & Trend Analysis
4.1. Nutraceuticals CDMO Market, By Dosage Form: Segment Dashboard
4.2. Nutraceuticals CDMO Market, By Dosage Form: Movement Analysis
4.3. Nutraceuticals CDMO Market Estimates & Forecasts, By Dosage Form, 2018 – 2030
4.3.1. Tablets & Capsules
4.3.1.1. Tablets & Capsules Nutraceuticals CDMO Market, 2018 to 2030 (USD Million)
4.3.2. Powder
4.3.2.1. Powder Nutraceuticals CDMO Market, 2018 to 2030 (USD Million)
4.3.3. Softgel
4.3.3.1. Softgel Nutraceuticals CDMO Market, 2018 to 2030 (USD Million)
4.3.4. Others
4.3.4.1. Others Nutraceuticals CDMO Market, 2018 to 2030 (USD Million)
Chapter 5. Nutraceuticals CDMO Market: Services Estimates & Trend Analysis
5.1. Nutraceuticals CDMO Market, By Services: Segment Dashboard
5.2. Nutraceuticals CDMO Market, By Services: Movement Analysis
5.3. Nutraceuticals CDMO Market Estimates & Forecasts, By Services, 2018 – 2030
5.3.1. Product Formulation and Development
5.3.1.1. Product Formulation and Development Nutraceuticals CDMO Market, 2018 to 2030 (USD Million)
5.3.2. Manufacturing and Packaging
5.3.2.1. Manufacturing and Packaging Nutraceuticals CDMO Market, 2018 to 2030 (USD Million)
5.3.3. Research & Development (R&D)
5.3.3.1. Research & Development (R&D) Nutraceuticals CDMO Market, 2018 to 2030 (USD Million)
5.3.4. Regulatory Compliance
5.3.4.1. Regulatory Compliance Nutraceuticals CDMO Market, 2018 to 2030 (USD Million)
5.3.5. Others
5.3.5.1. Others Nutraceuticals CDMO Market, 2018 to 2030 (USD Million)
Chapter 6. Nutraceuticals CDMO Market: Company Size Estimates & Trend Analysis
6.1. Nutraceuticals CDMO Market, By Company Size: Segment Dashboard
6.2. Nutraceuticals CDMO Market, By Company Size: Movement Analysis
6.3. Nutraceuticals CDMO Market Estimates & Forecasts, By Company Size, 2018 – 2030
6.3.1. Small Companies
6.3.1.1. Small Companies Nutraceuticals CDMO Market 2018 to 2030 (USD Million)
6.3.2. Mid-Sized Companies
6.3.2.1. Mid-Sized Companies Nutraceuticals CDMO Market 2018 to 2030 (USD Million)
6.3.3. Large Companies
6.3.3.1. Large Companies Nutraceuticals CDMO Market 2018 to 2030 (USD Million)
Chapter 7. Nutraceuticals CDMO Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2022 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. North America
7.4.1. Market Estimates and Forecast, 2018 – 2030 (Revenue, USD Million)
7.4.2. U.S.
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Regulatory Framework
7.4.2.4. U.S. Market Estimates and Forecasts, 2018 – 2030
7.4.3. Canada
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Regulatory Framework
7.4.3.4. Canada Market Estimates and Forecasts, 2018 – 2030
7.5. Europe
7.5.1. Market Estimates and Forecast, 2018 – 2030 (Revenue, USD Million)
7.5.2. UK
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Framework
7.5.2.4. UK Market Estimates and Forecasts, 2018 – 2030
7.5.3. Germany
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Framework
7.5.3.4. Germany Market Estimates and Forecasts, 2018 – 2030
7.5.4. France
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Regulatory Framework
7.5.4.4. France Market Estimates and Forecasts, 2018 – 2030
7.5.5. Italy
7.5.5.1. Key Country Dynamics
7.5.5.2. Competitive Scenario
7.5.5.3. Regulatory Framework
7.5.5.4. Italy Market Estimates and Forecasts, 2018 – 2030
7.5.6. Spain
7.5.6.1. Key Country Dynamics
7.5.6.2. Competitive Scenario
7.5.6.3. Regulatory Framework
7.5.6.4. Spain Market Estimates and Forecasts, 2018 – 2030
7.5.7. Denmark
7.5.7.1. Key Country Dynamics
7.5.7.2. Competitive Scenario
7.5.7.3. Regulatory Framework
7.5.7.4. Denmark Market Estimates and Forecasts, 2018 – 2030
7.5.8. Sweden
7.5.8.1. Key Country Dynamics
7.5.8.2. Competitive Scenario
7.5.8.3. Regulatory Framework
7.5.8.4. Sweden Market Estimates and Forecasts, 2018 – 2030
7.5.9. Norway
7.5.9.1. Key Country Dynamics
7.5.9.2. Competitive Scenario
7.5.9.3. Regulatory Framework
7.5.9.4. Norway Market Estimates and Forecasts, 2018 – 2030
7.6. Asia Pacific
7.6.1. Market Estimates and Forecast, 2018 – 2030 (Revenue, USD Million)
7.6.2. Japan
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Framework
7.6.2.4. Japan Market Estimates and Forecasts, 2018 – 2030
7.6.3. India
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Framework
7.6.3.4. India Market Estimates and Forecasts, 2018 – 2030
7.6.4. China
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Regulatory Framework
7.6.4.4. China Market Estimates and Forecasts, 2018 – 2030
7.6.5. South Korea
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Regulatory Framework
7.6.5.4. South Korea Market Estimates and Forecasts, 2018 – 2030
7.6.6. Australia
7.6.6.1. Key Country Dynamics
7.6.6.2. Competitive Scenario
7.6.6.3. Regulatory Framework
7.6.6.4. Australia Market Estimates and Forecasts, 2018 – 2030
7.6.7. Thailand
7.6.7.1. Key Country Dynamics
7.6.7.2. Competitive Scenario
7.6.7.3. Regulatory Framework
7.6.7.4. Thailand Market Estimates and Forecasts, 2018 – 2030
7.7. Latin America
7.7.1. Market Estimates and Forecast, 2018 – 2030 (Revenue, USD Million)
7.7.2. Brazil
7.7.2.1. Key Country Dynamics
7.7.2.2. Competitive Scenario
7.7.2.3. Regulatory Framework
7.7.2.4. Brazil Market Estimates and Forecasts, 2018 – 2030
7.7.3. Mexico
7.7.3.1. Key Country Dynamics
7.7.3.2. Competitive Scenario
7.7.3.3. Regulatory Framework
7.7.3.4. Mexico Market Estimates and Forecasts, 2018 – 2030
7.7.4. Argentina
7.7.4.1. Key Country Dynamics
7.7.4.2. Competitive Scenario
7.7.4.3. Regulatory Framework
7.7.4.4. Argentina Market Estimates and Forecasts, 2018 – 2030
7.8. MEA
7.8.1. Market Estimates and Forecast, 2018 – 2030 (Revenue, USD Million)
7.8.2. South Africa
7.8.2.1. Key Country Dynamics
7.8.2.2. Competitive Scenario
7.8.2.3. Regulatory Framework
7.8.2.4. South Africa Market Estimates and Forecasts, 2018 – 2030
7.8.3. Saudi Arabia
7.8.3.1. Key Country Dynamics
7.8.3.2. Competitive Scenario
7.8.3.3. Regulatory Framework
7.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 – 2030
7.8.4. UAE
7.8.4.1. Key Country Dynamics
7.8.4.2. Competitive Scenario
7.8.4.3. Regulatory Framework
7.8.4.4. UAE Market Estimates and Forecasts, 2018 – 2030
7.8.5. Kuwait
7.8.5.1. Key Country Dynamics
7.8.5.2. Competitive Scenario
7.8.5.3. Regulatory Framework
7.8.5.4. Kuwait Market Estimates and Forecasts, 2018 – 2030
Chapter 8. Competitive Landscape
8.1. Market Participant Categorization
8.1.1. Innovators
8.1.2. Market Leaders
8.1.3. Emerging Players
8.1.4. Company Market Share Analysis, 2022
8.2. Company Profiles
8.2.1. Catalent Inc.
8.2.1.1. Company Overview
8.2.1.2. Financial Performance
8.2.1.3. Service Benchmarking
8.2.1.4. Strategic Initiatives
8.2.2. Lonza Group AG
8.2.2.1. Company Overview
8.2.2.2. Financial Performance
8.2.2.3. Service Benchmarking
8.2.2.4. Strategic Initiatives
8.2.3. Nutrascience Labs
8.2.3.1. Company Overview
8.2.3.2. Financial Performance
8.2.3.3. Service Benchmarking
8.2.3.4. Strategic Initiatives
8.2.4. Robison Pharma, Inc.
8.2.4.1. Company Overview
8.2.4.2. Financial Performance
8.2.4.3. Service Benchmarking
8.2.4.4. Strategic Initiatives
8.2.5. Health Wright Products
8.2.5.1. Company Overview
8.2.5.2. Financial Performance
8.2.5.3. Service Benchmarking
8.2.5.4. Strategic Initiatives
8.2.6. Innovations in Nutrition + Wellness
8.2.6.1. Company Overview
8.2.6.2. Financial Performance
8.2.6.3. Service Benchmarking
8.2.6.4. Strategic Initiatives
8.2.7. INPHARMA S.p.A.
8.2.7.1. Company Overview
8.2.7.2. Financial Performance
8.2.7.3. Service Benchmarking
8.2.7.4. Strategic Initiatives
8.2.8. Aenova Group
8.2.8.1. Company Overview
8.2.8.2. Financial Performance
8.2.8.3. Service Benchmarking
8.2.8.4. Strategic Initiatives
8.2.9. NutraPakUSA
8.2.9.1. Company Overview
8.2.9.2. Financial Performance
8.2.9.3. Service Benchmarking
8.2.9.4. Strategic Initiatives
8.2.10. SFI Health Solutions
8.2.10.1. Company Overview
8.2.10.2. Financial Performance
8.2.10.3. Service Benchmarking
8.2.10.4. Strategic Initiatives
8.3. List of Private Players
Chapter 9. Key Takeaways/ KoL Commentary



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の頭蓋内狭窄症用ステント市場2023-2030：市場規模、シェア、動向分析
  • 医療用3D画像診断装置の世界市場2023-2030：市場規模、シェア、動向分析
  • 世界の静脈注射用鉄剤市場2023-2030：市場規模、シェア、動向分析
  • 胸部手術装置の世界市場2023-2030：市場規模、シェア、動向分析
  • リードレスペースメーカーの世界市場2023-2030：市場規模、シェア、動向分析
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GRV23JUN081 )"世界の栄養補助食品CDMO市場2023-2030：市場規模、シェア、動向分析" (英文：Nutraceuticals CDMO Market Size, Share & Trends Analysis Report By Dosage Form (Tablets, Softgel), By Services (Product Formulation & Development, Research & Development), By Company Size, By Region, And Segment Forecasts, 2023 - 2030)はGrand View Research社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。